<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36573390</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1598-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>50</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of Korean medical science</Title><ISOAbbreviation>J Korean Med Sci</ISOAbbreviation></Journal><ArticleTitle>Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine.</ArticleTitle><Pagination><StartPage>e357</StartPage><MedlinePgn>e357</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e357</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3346/jkms.2022.37.e357</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Finsterer</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2839-7305</Identifier><AffiliationInfo><Affiliation>Neurology &amp; Neurophysiology Center, Vienna, Austria. fipaps@yahoo.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Korean Med Sci</MedlineTA><NlmUniqueID>8703518</NlmUniqueID><ISSNLinking>1011-8934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SML2Y3J35T</RegistryNumber><NameOfSubstance UI="D003078">Colchicine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Korean Med Sci. 2022 Oct 24;37(41):e299. doi: 10.3346/jkms.2022.37.e299</RefSource><PMID Version="1">36281487</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003078" MajorTopicYN="Y">Colchicine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The author has no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36573390</ArticleId><ArticleId IdType="doi">10.3346/jkms.2022.37.e357</ArticleId><ArticleId IdType="pii">37.e357</ArticleId><ArticleId IdType="pmc">PMC9792258</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee HJ, Jeong YJ, Kim YJ, Kim SH. Multisystem inflammatory syndrome in an adult following COVID-19 mRNA vaccination: successful treatment with medium-dose steroids and colchicine. J Korean Med Sci. 2022;37(41):e299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9592940</ArticleId><ArticleId IdType="pubmed">36281487</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Long post-COVID vaccination syndrome. Brain Nerves. 2022 (online)  https://www.oatext.com/long-post-cOVID-vaccination-syndrome.php.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Abudalou M, Mohamed AS, Vega EA, Al Sbihi A. Colchicine-induced rhabdomyolysis: a review of 83 cases. BMJ Case Rep. 2021;14(7):e241977</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8296791</ArticleId><ArticleId IdType="pubmed">34290008</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C, et al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2008;27(1):129&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">17628739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehikhametalor K, Deans-Minott J, Duncan JP. Multisystem inflammatory syndrome in adults (MIS-A) after COVID-19 infection and recent vaccination with recombinant adenoviral vector encoding the spike protein antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria) J Intensive Care Med. 2023;38(2):232&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9389272</ArticleId><ArticleId IdType="pubmed">35979616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Jeong YJ, Kim YJ, Kim SH. Multisystem inflammatory syndrome in an adult following COVID-19 mRNA vaccination: successful treatment with medium-dose steroids and colchicine. J Korean Med Sci. 2022;37(41):e299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9592940</ArticleId><ArticleId IdType="pubmed">36281487</ArticleId></ArticleIdList></Reference><Reference><Citation>Finterer J, Scorza FA. A retrospective analysis of clinically confirmed long post-COVID vaccination syndrome. J Clin Transl Res. 2022;8(6):506&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9706319</ArticleId><ArticleId IdType="pubmed">36452006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037&#x2013;3049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904456</ArticleId><ArticleId IdType="pubmed">33640145</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>